Stay updated on NC318 Safety and Tolerability in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the NC318 Safety and Tolerability in Solid Tumors Clinical Trial page.

Latest updates to the NC318 Safety and Tolerability in Solid Tumors Clinical Trial page
- Check7 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check14 days agoNo Change Detected
- Check22 days agoChange DetectedThe webpage has undergone significant updates regarding the clinical study of the drug NC318, including a clearer description of the study phases and the removal of detailed inclusion and exclusion criteria for participants.SummaryDifference30%
- Check29 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check36 days agoChange DetectedDifference0.4%
- Check51 days agoChange DetectedDifference0.4%
- Check59 days agoChange DetectedDifference0.4%
Stay in the know with updates to NC318 Safety and Tolerability in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NC318 Safety and Tolerability in Solid Tumors Clinical Trial page.